These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36716550)

  • 1. Bridging the gaps towards precision psychiatry: Mechanistic biomarkers for early detection and intervention.
    Do KQ
    Psychiatry Res; 2023 Mar; 321():115064. PubMed ID: 36716550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caught in vicious circles: a perspective on dynamic feed-forward loops driving oxidative stress in schizophrenia.
    Cuenod M; Steullet P; Cabungcal JH; Dwir D; Khadimallah I; Klauser P; Conus P; Do KQ
    Mol Psychiatry; 2022 Apr; 27(4):1886-1897. PubMed ID: 34759358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A "central hub" in schizophrenia pathophysiology?
    Steullet P; Cabungcal JH; Monin A; Dwir D; O'Donnell P; Cuenod M; Do KQ
    Schizophr Res; 2016 Sep; 176(1):41-51. PubMed ID: 25000913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MMP9/RAGE pathway overactivation mediates redox dysregulation and neuroinflammation, leading to inhibitory/excitatory imbalance: a reverse translation study in schizophrenia patients.
    Dwir D; Giangreco B; Xin L; Tenenbaum L; Cabungcal JH; Steullet P; Goupil A; Cleusix M; Jenni R; Chtarto A; Baumann PS; Klauser P; Conus P; Tirouvanziam R; Cuenod M; Do KQ
    Mol Psychiatry; 2020 Nov; 25(11):2889-2904. PubMed ID: 30911107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redox dysregulation, neurodevelopment, and schizophrenia.
    Do KQ; Cabungcal JH; Frank A; Steullet P; Cuenod M
    Curr Opin Neurobiol; 2009 Apr; 19(2):220-30. PubMed ID: 19481443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Membrane lipids in schizophrenia and early phases of psychosis: Potential biomarkers and therapeutic targets?].
    Frajerman A; Kebir O; Chaumette B; Tessier C; Lamazière A; Nuss P; Krebs MO
    Encephale; 2020 Jun; 46(3):209-216. PubMed ID: 32151446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of the Mitochondrial Matrix Protein CyclophilinD Prevents Parvalbumin Interneuron Dysfunctionand Cognitive Deficits in a Mouse Model of NMDA Hypofunction.
    Phensy A; Lindquist KL; Lindquist KA; Bairuty D; Gauba E; Guo L; Tian J; Du H; Kroener S
    J Neurosci; 2020 Aug; 40(32):6121-6132. PubMed ID: 32605939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The origin of NMDA receptor hypofunction in schizophrenia.
    Nakazawa K; Sapkota K
    Pharmacol Ther; 2020 Jan; 205():107426. PubMed ID: 31629007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia.
    Gonzalez-Burgos G; Lewis DA
    Schizophr Bull; 2012 Sep; 38(5):950-7. PubMed ID: 22355184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered neural oscillations and behavior in a genetic mouse model of NMDA receptor hypofunction.
    Aguilar DD; Radzik LK; Schiffino FL; Folorunso OO; Zielinski MR; Coyle JT; Balu DT; McNally JM
    Sci Rep; 2021 Apr; 11(1):9031. PubMed ID: 33907230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurophysiological mechanisms of cortical plasticity impairments in schizophrenia and modulation by the NMDA receptor agonist D-serine.
    Kantrowitz JT; Epstein ML; Beggel O; Rohrig S; Lehrfeld JM; Revheim N; Lehrfeld NP; Reep J; Parker E; Silipo G; Ahissar M; Javitt DC
    Brain; 2016 Dec; 139(Pt 12):3281-3295. PubMed ID: 27913408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early auditory processing dysfunction in schizophrenia: Mechanisms and implications.
    Dondé C; Kantrowitz JT; Medalia A; Saperstein AM; Balla A; Sehatpour P; Martinez A; O'Connell MN; Javitt DC
    Neurosci Biobehav Rev; 2023 May; 148():105098. PubMed ID: 36796472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial, exosomal miR137-COX6A2 and gamma synchrony as biomarkers of parvalbumin interneurons, psychopathology, and neurocognition in schizophrenia.
    Khadimallah I; Jenni R; Cabungcal JH; Cleusix M; Fournier M; Beard E; Klauser P; Knebel JF; Murray MM; Retsa C; Siciliano M; Spencer KM; Steullet P; Cuenod M; Conus P; Do KQ
    Mol Psychiatry; 2022 Feb; 27(2):1192-1204. PubMed ID: 34686767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis.
    Hardingham GE; Do KQ
    Nat Rev Neurosci; 2016 Feb; 17(2):125-34. PubMed ID: 26763624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMDA receptor hypofunction for schizophrenia revisited: Perspectives from epigenetic mechanisms.
    Snyder MA; Gao WJ
    Schizophr Res; 2020 Mar; 217():60-70. PubMed ID: 30979669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Identification and Intervention of Schizophrenia: Insight From Hypotheses of Glutamate Dysfunction and Oxidative Stress.
    Lin CH; Lane HY
    Front Psychiatry; 2019; 10():93. PubMed ID: 30873052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute NMDA receptor antagonism impairs working memory performance but not attention in rats-Implications for the NMDAr hypofunction theory of schizophrenia.
    Lee J; van den Buuse M; Nithianantharajah J; Jones NC
    Behav Neurosci; 2020 Aug; 134(4):323-331. PubMed ID: 32658524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can N-Methyl-D-Aspartate Receptor Hypofunction in Schizophrenia Be Localized to an Individual Cell Type?
    Bygrave AM; Kilonzo K; Kullmann DM; Bannerman DM; Kätzel D
    Front Psychiatry; 2019; 10():835. PubMed ID: 31824347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated serum anti-NMDA receptor antibody levels in first-episode patients with schizophrenia.
    Tong J; Huang J; Luo X; Chen S; Cui Y; An H; Xiu M; Tan S; Wang Z; Yuan Y; Zhang J; Yang F; Li CR; Hong LE; Tan Y
    Brain Behav Immun; 2019 Oct; 81():213-219. PubMed ID: 31201848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroimaging Biomarkers in Schizophrenia.
    Kraguljac NV; McDonald WM; Widge AS; Rodriguez CI; Tohen M; Nemeroff CB
    Am J Psychiatry; 2021 Jun; 178(6):509-521. PubMed ID: 33397140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.